More Related Content
Similar to Emdogain by dr. maryam salman
Emdogain by dr. maryam salman
- 1. Emdogain® Done by: dr.Maryam alman Supervised by dr sundus faisal
- 2. What is Emdogain®? • Emdogain® is a unique, gel containing an enamel matrix derivative of porcine origin. Long-term clinical studies have demonstrated its effectiveness in inducing predictable regeneration of hard and soft tissues lost to periodontal disease or trauma.
- 3. Emdogain® in numbers: •Over 20 years on the market. • Over 2 million patients treated.* • Over 400 clinical and 800 scientific studies. • 10 year studies in intrabony and recession defects. • Extremely well tolerated.
- 4.
- 5. Modell of mechanismof Emdogain® : • Attraction • Attachment • Proliferation • Differentiation • Alveolar bone growth
- 6. Modell of mechanism:Attraction
- 7. Modell of mechanism:Attachment
- 8. Modell of mechanism:Proliferation
- 9. Modell of mechanism:Differentiation
- 10. Modell of mechanism:Alveolar bone
- 11. The concept usedin a periodontal defect Days Weeks Months One Year The enamel matrix protein forms a matrix on the root surface. Mesenchymal cells migrate into the lesion, attach to the surface and start to proliferate. Bone formation starts at the Emdogain® treated root surface and subsequently new alveolar bone will fill the defect. A new attachment with cementum and ligament is formed along the treated root surface A new functional attachment is achieved with time.
- 12.
- 13.
- 14. PrefGel™ (EDTA 24%*,pH 6.7) • Effectively removes smear-layer • Exposes the collagenous matrix of dentin surfaces • Does not induce any detectable necrosis in the surrounding periodontal tissues
- 15. Indications • Straumann® Emdogain®can be used to support early soft tissue wound healing in oral surgical procedures. • Straumann® Emdogain® can be used as part of flap surgeries in general comprising dental implantation and peri-implant procedures or as part of soft tissue grafting and gingivectomy procedures. • Straumann® Emdogain® used for Treatment of a self-containing defect
- 16. Straumann® Emdogain® usedfor Treatment of a self-containing defect
- 17. Straumann® Emdogain® usedfor Treatment of a self-containing defect
- 18. Straumann® Emdogain® usedfor Treatment of a self- containing defect
- 22. Use of Straumann®Emdogain® as part of implantationor peri-implant procedures involving submucosal healing
- 23. Use of Straumann®Emdogain® as part of implantationor peri-implant procedures involving transgingival healing
- 24. Use of Straumann®Emdogain® in combinationwith bone grafting procedures
- 25. Use of Straumann®Emdogain® in combinationwith membrane procedures
- 26. Donor sites ofsubepithelial connective tissue
- 27.
- 28. Post-surgical recommendations • Theuse of Straumann® Emdogain® does not necessitate any extra recommendations for post-surgical care other than those that are required by the procedure itself. General recommendations and considerations related to post- surgical care might include but are not limited to the following: • Suture materials should be used for extended stable flap closure. • No pressure should be applied to the flap after suturing. • The patient should be advised not to brush in the operated area, but rinse daily withan antiseptic mouth rinse (e.g. 0.1-0.2% chlorhexidine solution) until 3 weeks post-surgery. • Patients should also be instructed to avoid muscle traction or other trauma to the operated area for the same period. • Sutures are removed when clinical healing of the flap is stable and sutures no longer add to wound stability.
- 29. Advantage of emdogain 1.promote the regeneration of cementum, alveolar bone and periodontal ligament and to yield to significantly higher CAL (Clinical Attachment Level) 2. Emdogain® is also patient-friendly 3. has been demonstrated to significantly reduce post-surgical pain and swelling, 4. improve wound healing
- 30.
- 31.